Premium
Identification of a Novel DNA Gyrase Inhibitor via Design and Synthesis of New Antibacterial Pyrido[1′,2′:1,2]pyrimido[4,5‐ e ][1,3,4]thiadiazin‐5‐ol Derivatives
Author(s) -
Khalil Hosam H.,
Khattab Sherine N.,
Toughan Mayada M.,
ElSaghier Ahmed M. M.,
ElWakil Marwa H.
Publication year - 2020
Publication title -
chemistryselect
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 34
ISSN - 2365-6549
DOI - 10.1002/slct.202000886
Subject(s) - dna gyrase , dna supercoil , chemistry , stereochemistry , docking (animal) , ciprofloxacin , in silico , antibacterial activity , dna , combinatorial chemistry , escherichia coli , biochemistry , bacteria , biology , antibiotics , dna replication , genetics , medicine , nursing , gene
Two new series of pyrido[1′,2′:1,2]pyrimido[4,5‐ e ][1,3,4]thiadiazin‐5‐ol Schiff's bases ( 4 a‐j ) and 1,3,5‐triazinylaminobenzamides ( 6 a‐e ) as effective antibacterial agents targeting E.coli DNA gyrase were designed and synthesized. Compound 6 e was found to be the most promising antibacterial agent among the screened compounds. Further evaluation of the inhibitory activity of 6 e against E.coli DNA gyrase in the supercoiling assay revealed its potential inhibitory activity (IC 50 =4.86 μM) more than reference drug ciprofloxacin (IC 50 =4.98 μM). Comparison of molecular electrostatic potential maps between 6 e and ciprofloxacin revealed similar regions of positive and negative potentials. While docking studies illustrated the predicted binding mode of 6 e inside the active site of E.coli DNA gyrase which involved key binding interactions with the essential amino acid residues. Additional in silico computation of physicochemical parameters, ADMET and ligand efficiency indices pointed out to the potential drug‐like properties of 6 e as a lead compound for future optimization and development.